nodes	percent_of_prediction	percent_of_DWPC	metapath
Aripiprazole—ADRA2A—type 2 diabetes mellitus	0.111	0.42	CbGaD
Aripiprazole—HTR2C—type 2 diabetes mellitus	0.103	0.387	CbGaD
Aripiprazole—CYP3A4—type 2 diabetes mellitus	0.0512	0.193	CbGaD
Aripiprazole—DRD5—Bromocriptine—type 2 diabetes mellitus	0.0332	0.0759	CbGbCtD
Aripiprazole—HTR7—Bromocriptine—type 2 diabetes mellitus	0.0244	0.0556	CbGbCtD
Aripiprazole—DRD4—Bromocriptine—type 2 diabetes mellitus	0.0237	0.0541	CbGbCtD
Aripiprazole—HTR6—Bromocriptine—type 2 diabetes mellitus	0.0214	0.0488	CbGbCtD
Aripiprazole—HTR1D—Bromocriptine—type 2 diabetes mellitus	0.0195	0.0445	CbGbCtD
Aripiprazole—HTR2B—Bromocriptine—type 2 diabetes mellitus	0.0191	0.0436	CbGbCtD
Aripiprazole—HTR1B—Bromocriptine—type 2 diabetes mellitus	0.0187	0.0427	CbGbCtD
Aripiprazole—DRD3—Bromocriptine—type 2 diabetes mellitus	0.0176	0.0402	CbGbCtD
Aripiprazole—DRD1—Bromocriptine—type 2 diabetes mellitus	0.017	0.0388	CbGbCtD
Aripiprazole—ADRA2C—Bromocriptine—type 2 diabetes mellitus	0.017	0.0388	CbGbCtD
Aripiprazole—ADRA2B—Bromocriptine—type 2 diabetes mellitus	0.0161	0.0368	CbGbCtD
Aripiprazole—ADRB1—Bromocriptine—type 2 diabetes mellitus	0.0146	0.0334	CbGbCtD
Aripiprazole—ADRA1B—Bromocriptine—type 2 diabetes mellitus	0.0136	0.0311	CbGbCtD
Aripiprazole—HTR2C—Bromocriptine—type 2 diabetes mellitus	0.0124	0.0284	CbGbCtD
Aripiprazole—HTR1A—Bromocriptine—type 2 diabetes mellitus	0.0117	0.0267	CbGbCtD
Aripiprazole—ADRA2A—Bromocriptine—type 2 diabetes mellitus	0.0112	0.0256	CbGbCtD
Aripiprazole—HTR2A—Bromocriptine—type 2 diabetes mellitus	0.0112	0.0256	CbGbCtD
Aripiprazole—ADRA1A—Bromocriptine—type 2 diabetes mellitus	0.0107	0.0245	CbGbCtD
Aripiprazole—DRD2—Bromocriptine—type 2 diabetes mellitus	0.0103	0.0236	CbGbCtD
Aripiprazole—CYP3A7-CYP3A51P—Nateglinide—type 2 diabetes mellitus	0.00894	0.0204	CbGbCtD
Aripiprazole—CYP3A7—Nateglinide—type 2 diabetes mellitus	0.00894	0.0204	CbGbCtD
Aripiprazole—ABCB1—Linagliptin—type 2 diabetes mellitus	0.00893	0.0204	CbGbCtD
Aripiprazole—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.00796	0.0182	CbGbCtD
Aripiprazole—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.0067	0.0153	CbGbCtD
Aripiprazole—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.00576	0.0131	CbGbCtD
Aripiprazole—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.00542	0.0124	CbGbCtD
Aripiprazole—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00535	0.0122	CbGbCtD
Aripiprazole—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.00501	0.0114	CbGbCtD
Aripiprazole—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00477	0.0109	CbGbCtD
Aripiprazole—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00436	0.00996	CbGbCtD
Aripiprazole—CYP3A5—Losartan—type 2 diabetes mellitus	0.00414	0.00945	CbGbCtD
Aripiprazole—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00411	0.00938	CbGbCtD
Aripiprazole—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00395	0.00903	CbGbCtD
Aripiprazole—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00394	0.00899	CbGbCtD
Aripiprazole—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00381	0.0087	CbGbCtD
Aripiprazole—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00345	0.00787	CbGbCtD
Aripiprazole—ABCB1—Glyburide—type 2 diabetes mellitus	0.00295	0.00672	CbGbCtD
Aripiprazole—ABCB1—Losartan—type 2 diabetes mellitus	0.0027	0.00615	CbGbCtD
Aripiprazole—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00261	0.00596	CbGbCtD
Aripiprazole—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00251	0.00572	CbGbCtD
Aripiprazole—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00251	0.00572	CbGbCtD
Aripiprazole—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00237	0.00541	CbGbCtD
Aripiprazole—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00177	0.00403	CbGbCtD
Aripiprazole—HTR7—sympathetic nervous system—type 2 diabetes mellitus	0.00173	0.0532	CbGeAlD
Aripiprazole—HTR2A—arteriole—type 2 diabetes mellitus	0.00169	0.0521	CbGeAlD
Aripiprazole—CYP3A4—Losartan—type 2 diabetes mellitus	0.00161	0.00368	CbGbCtD
Aripiprazole—HTR7—autonomic nervous system—type 2 diabetes mellitus	0.00116	0.0358	CbGeAlD
Aripiprazole—HTR2A—sympathetic nervous system—type 2 diabetes mellitus	0.00108	0.0332	CbGeAlD
Aripiprazole—DRD1—nerve—type 2 diabetes mellitus	0.00104	0.0322	CbGeAlD
Aripiprazole—HTR3A—nerve—type 2 diabetes mellitus	0.00101	0.0311	CbGeAlD
Aripiprazole—HTR1B—artery—type 2 diabetes mellitus	0.000853	0.0263	CbGeAlD
Aripiprazole—HTR7—peripheral nervous system—type 2 diabetes mellitus	0.000837	0.0258	CbGeAlD
Aripiprazole—HTR1D—artery—type 2 diabetes mellitus	0.000826	0.0255	CbGeAlD
Aripiprazole—HTR2A—autonomic nervous system—type 2 diabetes mellitus	0.000723	0.0223	CbGeAlD
Aripiprazole—HTR2A—hindlimb—type 2 diabetes mellitus	0.000669	0.0206	CbGeAlD
Aripiprazole—HTR7—artery—type 2 diabetes mellitus	0.000658	0.0203	CbGeAlD
Aripiprazole—HTR7—nerve—type 2 diabetes mellitus	0.000652	0.0201	CbGeAlD
Aripiprazole—DRD2—nerve—type 2 diabetes mellitus	0.000617	0.019	CbGeAlD
Aripiprazole—ADRA2A—peripheral nervous system—type 2 diabetes mellitus	0.000614	0.0189	CbGeAlD
Aripiprazole—HTR7—endothelium—type 2 diabetes mellitus	0.000555	0.0171	CbGeAlD
Aripiprazole—HTR2A—peripheral nervous system—type 2 diabetes mellitus	0.000522	0.0161	CbGeAlD
Aripiprazole—H1F0—islet of Langerhans—type 2 diabetes mellitus	0.000512	0.0158	CbGeAlD
Aripiprazole—HTR3A—islet of Langerhans—type 2 diabetes mellitus	0.000488	0.0151	CbGeAlD
Aripiprazole—CYP3A7-CYP3A51P—nephron tubule—type 2 diabetes mellitus	0.000473	0.0146	CbGeAlD
Aripiprazole—H1F0—retina—type 2 diabetes mellitus	0.000438	0.0135	CbGeAlD
Aripiprazole—Cilostazol—CYP1A2—type 2 diabetes mellitus	0.000437	0.141	CrCbGaD
Aripiprazole—H1F0—nephron tubule—type 2 diabetes mellitus	0.000412	0.0127	CbGeAlD
Aripiprazole—HTR2A—artery—type 2 diabetes mellitus	0.00041	0.0127	CbGeAlD
Aripiprazole—HTR2A—nerve—type 2 diabetes mellitus	0.000407	0.0126	CbGeAlD
Aripiprazole—CYP3A7-CYP3A51P—cortex of kidney—type 2 diabetes mellitus	0.000405	0.0125	CbGeAlD
Aripiprazole—ADRA1B—kidney—type 2 diabetes mellitus	0.000384	0.0118	CbGeAlD
Aripiprazole—H1F0—cardiovascular system—type 2 diabetes mellitus	0.00037	0.0114	CbGeAlD
Aripiprazole—H1F0—kidney—type 2 diabetes mellitus	0.000362	0.0112	CbGeAlD
Aripiprazole—H1F0—pancreas—type 2 diabetes mellitus	0.00036	0.0111	CbGeAlD
Aripiprazole—H1F0—cortex of kidney—type 2 diabetes mellitus	0.000353	0.0109	CbGeAlD
Aripiprazole—HTR2A—endothelium—type 2 diabetes mellitus	0.000346	0.0107	CbGeAlD
Aripiprazole—H1F0—adipose tissue—type 2 diabetes mellitus	0.000327	0.0101	CbGeAlD
Aripiprazole—CYP3A7—liver—type 2 diabetes mellitus	0.000309	0.00953	CbGeAlD
Aripiprazole—HTR1B—cardiovascular system—type 2 diabetes mellitus	0.000296	0.00914	CbGeAlD
Aripiprazole—CHRM2—cardiovascular system—type 2 diabetes mellitus	0.000295	0.0091	CbGeAlD
Aripiprazole—KCNH2—islet of Langerhans—type 2 diabetes mellitus	0.000294	0.00908	CbGeAlD
Aripiprazole—Cilostazol—CYP3A4—type 2 diabetes mellitus	0.000289	0.0932	CrCbGaD
Aripiprazole—HTR1D—cardiovascular system—type 2 diabetes mellitus	0.000287	0.00885	CbGeAlD
Aripiprazole—HTR1D—kidney—type 2 diabetes mellitus	0.000281	0.00866	CbGeAlD
Aripiprazole—ADRB1—cardiovascular system—type 2 diabetes mellitus	0.000279	0.0086	CbGeAlD
Aripiprazole—CHRM1—cardiovascular system—type 2 diabetes mellitus	0.000268	0.00828	CbGeAlD
Aripiprazole—HTR2B—cardiovascular system—type 2 diabetes mellitus	0.000267	0.00824	CbGeAlD
Aripiprazole—CYP3A7-CYP3A51P—liver—type 2 diabetes mellitus	0.000263	0.00811	CbGeAlD
Aripiprazole—DRD2—retina—type 2 diabetes mellitus	0.000255	0.00788	CbGeAlD
Aripiprazole—HTR2B—cortex of kidney—type 2 diabetes mellitus	0.000254	0.00785	CbGeAlD
Aripiprazole—Vilazodone—CYP3A4—type 2 diabetes mellitus	0.000246	0.0793	CrCbGaD
Aripiprazole—ADRB1—adipose tissue—type 2 diabetes mellitus	0.000246	0.00759	CbGeAlD
Aripiprazole—CYP3A5—islet of Langerhans—type 2 diabetes mellitus	0.000243	0.0075	CbGeAlD
Aripiprazole—HTR1A—cardiovascular system—type 2 diabetes mellitus	0.000239	0.00738	CbGeAlD
Aripiprazole—HTR2B—adipose tissue—type 2 diabetes mellitus	0.000235	0.00726	CbGeAlD
Aripiprazole—CHRM3—kidney—type 2 diabetes mellitus	0.000235	0.00725	CbGeAlD
Aripiprazole—ADRA2C—nephron tubule—type 2 diabetes mellitus	0.000234	0.00722	CbGeAlD
Aripiprazole—ADRA2A—islet of Langerhans—type 2 diabetes mellitus	0.000232	0.00715	CbGeAlD
Aripiprazole—H1F0—liver—type 2 diabetes mellitus	0.000229	0.00707	CbGeAlD
Aripiprazole—HTR7—cardiovascular system—type 2 diabetes mellitus	0.000229	0.00705	CbGeAlD
Aripiprazole—HTR7—kidney—type 2 diabetes mellitus	0.000224	0.0069	CbGeAlD
Aripiprazole—Perphenazine—CALM1—type 2 diabetes mellitus	0.000223	0.0718	CrCbGaD
Aripiprazole—ADRA1A—cardiovascular system—type 2 diabetes mellitus	0.00022	0.0068	CbGeAlD
Aripiprazole—KCNH2—cardiovascular system—type 2 diabetes mellitus	0.000213	0.00657	CbGeAlD
Aripiprazole—CHRM3—adipose tissue—type 2 diabetes mellitus	0.000212	0.00653	CbGeAlD
Aripiprazole—ADRA2C—kidney—type 2 diabetes mellitus	0.000206	0.00634	CbGeAlD
Aripiprazole—ADRA2C—pancreas—type 2 diabetes mellitus	0.000204	0.0063	CbGeAlD
Aripiprazole—Ziprasidone—ADRA2A—type 2 diabetes mellitus	0.000203	0.0653	CrCbGaD
Aripiprazole—ADRA2C—cortex of kidney—type 2 diabetes mellitus	0.0002	0.00618	CbGeAlD
Aripiprazole—CYP3A5—nephron tubule—type 2 diabetes mellitus	0.000196	0.00604	CbGeAlD
Aripiprazole—ADRA1A—adipose tissue—type 2 diabetes mellitus	0.000194	0.006	CbGeAlD
Aripiprazole—Ziprasidone—HTR2C—type 2 diabetes mellitus	0.000186	0.0601	CrCbGaD
Aripiprazole—ADRA2C—adipose tissue—type 2 diabetes mellitus	0.000185	0.00572	CbGeAlD
Aripiprazole—CYP3A5—kidney—type 2 diabetes mellitus	0.000172	0.00531	CbGeAlD
Aripiprazole—CYP3A5—pancreas—type 2 diabetes mellitus	0.000171	0.00527	CbGeAlD
Aripiprazole—Nefazodone—ADRA2A—type 2 diabetes mellitus	0.00017	0.0549	CrCbGaD
Aripiprazole—HTR2A—retina—type 2 diabetes mellitus	0.000168	0.0052	CbGeAlD
Aripiprazole—CYP3A5—cortex of kidney—type 2 diabetes mellitus	0.000168	0.00517	CbGeAlD
Aripiprazole—ADRA2A—pancreas—type 2 diabetes mellitus	0.000163	0.00503	CbGeAlD
Aripiprazole—ADRA2A—cortex of kidney—type 2 diabetes mellitus	0.00016	0.00493	CbGeAlD
Aripiprazole—Trazodone—ADRA2A—type 2 diabetes mellitus	0.000158	0.0508	CrCbGaD
Aripiprazole—Nefazodone—HTR2C—type 2 diabetes mellitus	0.000157	0.0505	CrCbGaD
Aripiprazole—CYP3A5—adipose tissue—type 2 diabetes mellitus	0.000155	0.00478	CbGeAlD
Aripiprazole—HRH1—adipose tissue—type 2 diabetes mellitus	0.00015	0.00464	CbGeAlD
Aripiprazole—ADRA2A—adipose tissue—type 2 diabetes mellitus	0.000148	0.00456	CbGeAlD
Aripiprazole—Trazodone—HTR2C—type 2 diabetes mellitus	0.000145	0.0467	CrCbGaD
Aripiprazole—HTR2A—cardiovascular system—type 2 diabetes mellitus	0.000143	0.0044	CbGeAlD
Aripiprazole—HTR7—liver—type 2 diabetes mellitus	0.000141	0.00436	CbGeAlD
Aripiprazole—Ziprasidone—CYP1A2—type 2 diabetes mellitus	0.000141	0.0453	CrCbGaD
Aripiprazole—HTR2A—kidney—type 2 diabetes mellitus	0.000139	0.0043	CbGeAlD
Aripiprazole—ADRA1A—liver—type 2 diabetes mellitus	0.000136	0.00421	CbGeAlD
Aripiprazole—ADRA2C—liver—type 2 diabetes mellitus	0.00013	0.00401	CbGeAlD
Aripiprazole—Prochlorperazine—HTR2C—type 2 diabetes mellitus	0.00013	0.0419	CrCbGaD
Aripiprazole—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.000129	0.00398	CbGeAlD
Aripiprazole—CYP3A4—kidney—type 2 diabetes mellitus	0.000129	0.00398	CbGeAlD
Aripiprazole—CYP2D6—kidney—type 2 diabetes mellitus	0.000127	0.00392	CbGeAlD
Aripiprazole—ABCB1—retina—type 2 diabetes mellitus	0.00011	0.00341	CbGeAlD
Aripiprazole—CYP3A5—liver—type 2 diabetes mellitus	0.000109	0.00336	CbGeAlD
Aripiprazole—ABCB1—nephron tubule—type 2 diabetes mellitus	0.000104	0.00321	CbGeAlD
Aripiprazole—Perphenazine—ADRA2A—type 2 diabetes mellitus	0.000101	0.0325	CrCbGaD
Aripiprazole—ABCB1—cardiovascular system—type 2 diabetes mellitus	9.34e-05	0.00288	CbGeAlD
Aripiprazole—Ziprasidone—CYP3A4—type 2 diabetes mellitus	9.32e-05	0.03	CrCbGaD
Aripiprazole—Perphenazine—HTR2C—type 2 diabetes mellitus	9.29e-05	0.0299	CrCbGaD
Aripiprazole—ABCB1—kidney—type 2 diabetes mellitus	9.14e-05	0.00282	CbGeAlD
Aripiprazole—ABCB1—pancreas—type 2 diabetes mellitus	9.08e-05	0.0028	CbGeAlD
Aripiprazole—ABCB1—cortex of kidney—type 2 diabetes mellitus	8.9e-05	0.00275	CbGeAlD
Aripiprazole—HTR2A—liver—type 2 diabetes mellitus	8.81e-05	0.00272	CbGeAlD
Aripiprazole—ABCB1—adipose tissue—type 2 diabetes mellitus	8.23e-05	0.00254	CbGeAlD
Aripiprazole—CYP3A4—liver—type 2 diabetes mellitus	8.16e-05	0.00252	CbGeAlD
Aripiprazole—CYP2D6—liver—type 2 diabetes mellitus	8.03e-05	0.00248	CbGeAlD
Aripiprazole—Nefazodone—CYP3A4—type 2 diabetes mellitus	7.83e-05	0.0252	CrCbGaD
Aripiprazole—Trazodone—CYP3A4—type 2 diabetes mellitus	7.24e-05	0.0233	CrCbGaD
Aripiprazole—Perphenazine—CYP1A2—type 2 diabetes mellitus	7.01e-05	0.0226	CrCbGaD
Aripiprazole—Prochlorperazine—CYP3A4—type 2 diabetes mellitus	6.49e-05	0.0209	CrCbGaD
Aripiprazole—ABCB1—liver—type 2 diabetes mellitus	5.78e-05	0.00178	CbGeAlD
Aripiprazole—Perphenazine—CYP3A4—type 2 diabetes mellitus	4.64e-05	0.0149	CrCbGaD
Aripiprazole—Thrombocytopenia—Metformin—type 2 diabetes mellitus	3.07e-05	0.000192	CcSEcCtD
Aripiprazole—Dyspnoea—Valsartan—type 2 diabetes mellitus	3.07e-05	0.000192	CcSEcCtD
Aripiprazole—Vertigo—Losartan—type 2 diabetes mellitus	3.07e-05	0.000192	CcSEcCtD
Aripiprazole—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	3.07e-05	0.000192	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	3.07e-05	0.000192	CcSEcCtD
Aripiprazole—Somnolence—Valsartan—type 2 diabetes mellitus	3.06e-05	0.000192	CcSEcCtD
Aripiprazole—Syncope—Losartan—type 2 diabetes mellitus	3.06e-05	0.000192	CcSEcCtD
Aripiprazole—Paraesthesia—Orlistat—type 2 diabetes mellitus	3.06e-05	0.000191	CcSEcCtD
Aripiprazole—Leukopenia—Losartan—type 2 diabetes mellitus	3.05e-05	0.000191	CcSEcCtD
Aripiprazole—Discomfort—Irbesartan—type 2 diabetes mellitus	3.05e-05	0.000191	CcSEcCtD
Aripiprazole—Skin disorder—Metformin—type 2 diabetes mellitus	3.05e-05	0.000191	CcSEcCtD
Aripiprazole—Immune system disorder—Ramipril—type 2 diabetes mellitus	3.04e-05	0.00019	CcSEcCtD
Aripiprazole—Hyperhidrosis—Metformin—type 2 diabetes mellitus	3.03e-05	0.00019	CcSEcCtD
Aripiprazole—Dyspepsia—Valsartan—type 2 diabetes mellitus	3.03e-05	0.00019	CcSEcCtD
Aripiprazole—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	3.03e-05	0.00019	CcSEcCtD
Aripiprazole—Dizziness—Bromocriptine—type 2 diabetes mellitus	3.02e-05	0.000189	CcSEcCtD
Aripiprazole—Dry mouth—Irbesartan—type 2 diabetes mellitus	3.02e-05	0.000189	CcSEcCtD
Aripiprazole—Palpitations—Losartan—type 2 diabetes mellitus	3.02e-05	0.000189	CcSEcCtD
Aripiprazole—Nausea—Glimepiride—type 2 diabetes mellitus	3.01e-05	0.000188	CcSEcCtD
Aripiprazole—Loss of consciousness—Losartan—type 2 diabetes mellitus	3e-05	0.000188	CcSEcCtD
Aripiprazole—Nausea—Sitagliptin—type 2 diabetes mellitus	3e-05	0.000188	CcSEcCtD
Aripiprazole—Dyspepsia—Orlistat—type 2 diabetes mellitus	3e-05	0.000188	CcSEcCtD
Aripiprazole—Asthenia—Glyburide—type 2 diabetes mellitus	3e-05	0.000188	CcSEcCtD
Aripiprazole—Decreased appetite—Valsartan—type 2 diabetes mellitus	2.99e-05	0.000187	CcSEcCtD
Aripiprazole—Anorexia—Metformin—type 2 diabetes mellitus	2.99e-05	0.000187	CcSEcCtD
Aripiprazole—Cough—Losartan—type 2 diabetes mellitus	2.98e-05	0.000187	CcSEcCtD
Aripiprazole—Urticaria—Gliclazide—type 2 diabetes mellitus	2.98e-05	0.000186	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	2.97e-05	0.000186	CcSEcCtD
Aripiprazole—Alopecia—Ramipril—type 2 diabetes mellitus	2.97e-05	0.000186	CcSEcCtD
Aripiprazole—Fatigue—Valsartan—type 2 diabetes mellitus	2.97e-05	0.000186	CcSEcCtD
Aripiprazole—Abdominal pain—Gliclazide—type 2 diabetes mellitus	2.96e-05	0.000186	CcSEcCtD
Aripiprazole—Body temperature increased—Gliclazide—type 2 diabetes mellitus	2.96e-05	0.000186	CcSEcCtD
Aripiprazole—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	2.96e-05	0.000185	CcSEcCtD
Aripiprazole—Oedema—Irbesartan—type 2 diabetes mellitus	2.96e-05	0.000185	CcSEcCtD
Aripiprazole—Decreased appetite—Orlistat—type 2 diabetes mellitus	2.96e-05	0.000185	CcSEcCtD
Aripiprazole—Pruritus—Glyburide—type 2 diabetes mellitus	2.95e-05	0.000185	CcSEcCtD
Aripiprazole—Mental disorder—Ramipril—type 2 diabetes mellitus	2.95e-05	0.000184	CcSEcCtD
Aripiprazole—Constipation—Valsartan—type 2 diabetes mellitus	2.95e-05	0.000184	CcSEcCtD
Aripiprazole—Infection—Irbesartan—type 2 diabetes mellitus	2.94e-05	0.000184	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	2.94e-05	0.000184	CcSEcCtD
Aripiprazole—Fatigue—Orlistat—type 2 diabetes mellitus	2.93e-05	0.000184	CcSEcCtD
Aripiprazole—Hypotension—Metformin—type 2 diabetes mellitus	2.93e-05	0.000184	CcSEcCtD
Aripiprazole—Malnutrition—Ramipril—type 2 diabetes mellitus	2.93e-05	0.000183	CcSEcCtD
Aripiprazole—Erythema—Ramipril—type 2 diabetes mellitus	2.93e-05	0.000183	CcSEcCtD
Aripiprazole—Shock—Irbesartan—type 2 diabetes mellitus	2.91e-05	0.000182	CcSEcCtD
Aripiprazole—Pain—Orlistat—type 2 diabetes mellitus	2.91e-05	0.000182	CcSEcCtD
Aripiprazole—Arthralgia—Losartan—type 2 diabetes mellitus	2.91e-05	0.000182	CcSEcCtD
Aripiprazole—Myalgia—Losartan—type 2 diabetes mellitus	2.91e-05	0.000182	CcSEcCtD
Aripiprazole—Chest pain—Losartan—type 2 diabetes mellitus	2.91e-05	0.000182	CcSEcCtD
Aripiprazole—Vomiting—Bromocriptine—type 2 diabetes mellitus	2.9e-05	0.000182	CcSEcCtD
Aripiprazole—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	2.9e-05	0.000182	CcSEcCtD
Aripiprazole—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	2.9e-05	0.000181	CcSEcCtD
Aripiprazole—Anxiety—Losartan—type 2 diabetes mellitus	2.9e-05	0.000181	CcSEcCtD
Aripiprazole—Tachycardia—Irbesartan—type 2 diabetes mellitus	2.89e-05	0.000181	CcSEcCtD
Aripiprazole—Rash—Bromocriptine—type 2 diabetes mellitus	2.88e-05	0.00018	CcSEcCtD
Aripiprazole—Dermatitis—Bromocriptine—type 2 diabetes mellitus	2.88e-05	0.00018	CcSEcCtD
Aripiprazole—Skin disorder—Irbesartan—type 2 diabetes mellitus	2.87e-05	0.00018	CcSEcCtD
Aripiprazole—Tension—Ramipril—type 2 diabetes mellitus	2.87e-05	0.00018	CcSEcCtD
Aripiprazole—Discomfort—Losartan—type 2 diabetes mellitus	2.87e-05	0.00018	CcSEcCtD
Aripiprazole—Dysgeusia—Ramipril—type 2 diabetes mellitus	2.87e-05	0.000179	CcSEcCtD
Aripiprazole—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	2.86e-05	0.000179	CcSEcCtD
Aripiprazole—Headache—Bromocriptine—type 2 diabetes mellitus	2.86e-05	0.000179	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	2.86e-05	0.000179	CcSEcCtD
Aripiprazole—Diarrhoea—Glyburide—type 2 diabetes mellitus	2.86e-05	0.000179	CcSEcCtD
Aripiprazole—Nervousness—Ramipril—type 2 diabetes mellitus	2.84e-05	0.000178	CcSEcCtD
Aripiprazole—Dry mouth—Losartan—type 2 diabetes mellitus	2.84e-05	0.000178	CcSEcCtD
Aripiprazole—Anorexia—Irbesartan—type 2 diabetes mellitus	2.82e-05	0.000177	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	2.82e-05	0.000176	CcSEcCtD
Aripiprazole—Paraesthesia—Metformin—type 2 diabetes mellitus	2.82e-05	0.000176	CcSEcCtD
Aripiprazole—Muscle spasms—Ramipril—type 2 diabetes mellitus	2.81e-05	0.000176	CcSEcCtD
Aripiprazole—Confusional state—Losartan—type 2 diabetes mellitus	2.81e-05	0.000176	CcSEcCtD
Aripiprazole—Feeling abnormal—Orlistat—type 2 diabetes mellitus	2.8e-05	0.000176	CcSEcCtD
Aripiprazole—Dyspnoea—Metformin—type 2 diabetes mellitus	2.8e-05	0.000175	CcSEcCtD
Aripiprazole—Somnolence—Metformin—type 2 diabetes mellitus	2.79e-05	0.000175	CcSEcCtD
Aripiprazole—Anaphylactic shock—Losartan—type 2 diabetes mellitus	2.79e-05	0.000174	CcSEcCtD
Aripiprazole—Oedema—Losartan—type 2 diabetes mellitus	2.79e-05	0.000174	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	2.78e-05	0.000174	CcSEcCtD
Aripiprazole—Infection—Losartan—type 2 diabetes mellitus	2.77e-05	0.000173	CcSEcCtD
Aripiprazole—Hypotension—Irbesartan—type 2 diabetes mellitus	2.77e-05	0.000173	CcSEcCtD
Aripiprazole—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	2.76e-05	0.000173	CcSEcCtD
Aripiprazole—Dyspepsia—Metformin—type 2 diabetes mellitus	2.76e-05	0.000173	CcSEcCtD
Aripiprazole—Tremor—Ramipril—type 2 diabetes mellitus	2.74e-05	0.000172	CcSEcCtD
Aripiprazole—Shock—Losartan—type 2 diabetes mellitus	2.74e-05	0.000172	CcSEcCtD
Aripiprazole—Urticaria—Valsartan—type 2 diabetes mellitus	2.74e-05	0.000171	CcSEcCtD
Aripiprazole—Nervous system disorder—Losartan—type 2 diabetes mellitus	2.73e-05	0.000171	CcSEcCtD
Aripiprazole—Thrombocytopenia—Losartan—type 2 diabetes mellitus	2.73e-05	0.000171	CcSEcCtD
Aripiprazole—Decreased appetite—Metformin—type 2 diabetes mellitus	2.73e-05	0.000171	CcSEcCtD
Aripiprazole—Abdominal pain—Valsartan—type 2 diabetes mellitus	2.72e-05	0.00017	CcSEcCtD
Aripiprazole—Tachycardia—Losartan—type 2 diabetes mellitus	2.72e-05	0.00017	CcSEcCtD
Aripiprazole—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	2.72e-05	0.00017	CcSEcCtD
Aripiprazole—Nausea—Bromocriptine—type 2 diabetes mellitus	2.71e-05	0.00017	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	2.71e-05	0.00017	CcSEcCtD
Aripiprazole—Fatigue—Metformin—type 2 diabetes mellitus	2.7e-05	0.000169	CcSEcCtD
Aripiprazole—Urticaria—Orlistat—type 2 diabetes mellitus	2.7e-05	0.000169	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	2.7e-05	0.000169	CcSEcCtD
Aripiprazole—Hyperhidrosis—Losartan—type 2 diabetes mellitus	2.69e-05	0.000169	CcSEcCtD
Aripiprazole—Abdominal pain—Orlistat—type 2 diabetes mellitus	2.69e-05	0.000168	CcSEcCtD
Aripiprazole—Body temperature increased—Orlistat—type 2 diabetes mellitus	2.69e-05	0.000168	CcSEcCtD
Aripiprazole—Asthenia—Gliclazide—type 2 diabetes mellitus	2.69e-05	0.000168	CcSEcCtD
Aripiprazole—Agitation—Ramipril—type 2 diabetes mellitus	2.69e-05	0.000168	CcSEcCtD
Aripiprazole—Constipation—Metformin—type 2 diabetes mellitus	2.68e-05	0.000168	CcSEcCtD
Aripiprazole—Angioedema—Ramipril—type 2 diabetes mellitus	2.67e-05	0.000167	CcSEcCtD
Aripiprazole—Paraesthesia—Irbesartan—type 2 diabetes mellitus	2.66e-05	0.000166	CcSEcCtD
Aripiprazole—Anorexia—Losartan—type 2 diabetes mellitus	2.65e-05	0.000166	CcSEcCtD
Aripiprazole—Vomiting—Glyburide—type 2 diabetes mellitus	2.65e-05	0.000166	CcSEcCtD
Aripiprazole—Pruritus—Gliclazide—type 2 diabetes mellitus	2.65e-05	0.000166	CcSEcCtD
Aripiprazole—Malaise—Ramipril—type 2 diabetes mellitus	2.64e-05	0.000165	CcSEcCtD
Aripiprazole—Dyspnoea—Irbesartan—type 2 diabetes mellitus	2.64e-05	0.000165	CcSEcCtD
Aripiprazole—Rash—Glyburide—type 2 diabetes mellitus	2.63e-05	0.000165	CcSEcCtD
Aripiprazole—Somnolence—Irbesartan—type 2 diabetes mellitus	2.63e-05	0.000165	CcSEcCtD
Aripiprazole—Dermatitis—Glyburide—type 2 diabetes mellitus	2.63e-05	0.000165	CcSEcCtD
Aripiprazole—Vertigo—Ramipril—type 2 diabetes mellitus	2.63e-05	0.000165	CcSEcCtD
Aripiprazole—Syncope—Ramipril—type 2 diabetes mellitus	2.62e-05	0.000164	CcSEcCtD
Aripiprazole—Leukopenia—Ramipril—type 2 diabetes mellitus	2.62e-05	0.000164	CcSEcCtD
Aripiprazole—Headache—Glyburide—type 2 diabetes mellitus	2.62e-05	0.000164	CcSEcCtD
Aripiprazole—Dyspepsia—Irbesartan—type 2 diabetes mellitus	2.61e-05	0.000163	CcSEcCtD
Aripiprazole—Hypotension—Losartan—type 2 diabetes mellitus	2.6e-05	0.000163	CcSEcCtD
Aripiprazole—Palpitations—Ramipril—type 2 diabetes mellitus	2.59e-05	0.000162	CcSEcCtD
Aripiprazole—Feeling abnormal—Metformin—type 2 diabetes mellitus	2.58e-05	0.000162	CcSEcCtD
Aripiprazole—Decreased appetite—Irbesartan—type 2 diabetes mellitus	2.57e-05	0.000161	CcSEcCtD
Aripiprazole—Loss of consciousness—Ramipril—type 2 diabetes mellitus	2.57e-05	0.000161	CcSEcCtD
Aripiprazole—Diarrhoea—Gliclazide—type 2 diabetes mellitus	2.56e-05	0.000161	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	2.56e-05	0.000161	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	2.56e-05	0.00016	CcSEcCtD
Aripiprazole—Cough—Ramipril—type 2 diabetes mellitus	2.55e-05	0.00016	CcSEcCtD
Aripiprazole—Fatigue—Irbesartan—type 2 diabetes mellitus	2.55e-05	0.00016	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	2.54e-05	0.000159	CcSEcCtD
Aripiprazole—Hypersensitivity—Valsartan—type 2 diabetes mellitus	2.54e-05	0.000159	CcSEcCtD
Aripiprazole—Convulsion—Ramipril—type 2 diabetes mellitus	2.54e-05	0.000159	CcSEcCtD
Aripiprazole—Pain—Irbesartan—type 2 diabetes mellitus	2.53e-05	0.000159	CcSEcCtD
Aripiprazole—Constipation—Irbesartan—type 2 diabetes mellitus	2.53e-05	0.000159	CcSEcCtD
Aripiprazole—Insomnia—Losartan—type 2 diabetes mellitus	2.52e-05	0.000158	CcSEcCtD
Aripiprazole—Hypersensitivity—Orlistat—type 2 diabetes mellitus	2.51e-05	0.000157	CcSEcCtD
Aripiprazole—Paraesthesia—Losartan—type 2 diabetes mellitus	2.5e-05	0.000157	CcSEcCtD
Aripiprazole—Urticaria—Metformin—type 2 diabetes mellitus	2.49e-05	0.000156	CcSEcCtD
Aripiprazole—Chest pain—Ramipril—type 2 diabetes mellitus	2.49e-05	0.000156	CcSEcCtD
Aripiprazole—Myalgia—Ramipril—type 2 diabetes mellitus	2.49e-05	0.000156	CcSEcCtD
Aripiprazole—Arthralgia—Ramipril—type 2 diabetes mellitus	2.49e-05	0.000156	CcSEcCtD
Aripiprazole—Dyspnoea—Losartan—type 2 diabetes mellitus	2.48e-05	0.000156	CcSEcCtD
Aripiprazole—Anxiety—Ramipril—type 2 diabetes mellitus	2.48e-05	0.000155	CcSEcCtD
Aripiprazole—Nausea—Glyburide—type 2 diabetes mellitus	2.48e-05	0.000155	CcSEcCtD
Aripiprazole—Abdominal pain—Metformin—type 2 diabetes mellitus	2.48e-05	0.000155	CcSEcCtD
Aripiprazole—Dizziness—Gliclazide—type 2 diabetes mellitus	2.48e-05	0.000155	CcSEcCtD
Aripiprazole—Somnolence—Losartan—type 2 diabetes mellitus	2.48e-05	0.000155	CcSEcCtD
Aripiprazole—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	2.47e-05	0.000155	CcSEcCtD
Aripiprazole—Asthenia—Valsartan—type 2 diabetes mellitus	2.47e-05	0.000155	CcSEcCtD
Aripiprazole—Discomfort—Ramipril—type 2 diabetes mellitus	2.46e-05	0.000154	CcSEcCtD
Aripiprazole—Dyspepsia—Losartan—type 2 diabetes mellitus	2.45e-05	0.000154	CcSEcCtD
Aripiprazole—Asthenia—Orlistat—type 2 diabetes mellitus	2.44e-05	0.000153	CcSEcCtD
Aripiprazole—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	2.44e-05	0.000153	CcSEcCtD
Aripiprazole—Pruritus—Valsartan—type 2 diabetes mellitus	2.44e-05	0.000153	CcSEcCtD
Aripiprazole—Dry mouth—Ramipril—type 2 diabetes mellitus	2.44e-05	0.000153	CcSEcCtD
Aripiprazole—Decreased appetite—Losartan—type 2 diabetes mellitus	2.42e-05	0.000152	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	2.42e-05	0.000152	CcSEcCtD
Aripiprazole—Confusional state—Ramipril—type 2 diabetes mellitus	2.41e-05	0.000151	CcSEcCtD
Aripiprazole—Pruritus—Orlistat—type 2 diabetes mellitus	2.41e-05	0.000151	CcSEcCtD
Aripiprazole—Fatigue—Losartan—type 2 diabetes mellitus	2.4e-05	0.00015	CcSEcCtD
Aripiprazole—Oedema—Ramipril—type 2 diabetes mellitus	2.39e-05	0.00015	CcSEcCtD
Aripiprazole—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	2.39e-05	0.00015	CcSEcCtD
Aripiprazole—Vomiting—Gliclazide—type 2 diabetes mellitus	2.38e-05	0.000149	CcSEcCtD
Aripiprazole—Pain—Losartan—type 2 diabetes mellitus	2.38e-05	0.000149	CcSEcCtD
Aripiprazole—Constipation—Losartan—type 2 diabetes mellitus	2.38e-05	0.000149	CcSEcCtD
Aripiprazole—Rash—Gliclazide—type 2 diabetes mellitus	2.36e-05	0.000148	CcSEcCtD
Aripiprazole—Dermatitis—Gliclazide—type 2 diabetes mellitus	2.36e-05	0.000148	CcSEcCtD
Aripiprazole—Diarrhoea—Valsartan—type 2 diabetes mellitus	2.36e-05	0.000148	CcSEcCtD
Aripiprazole—Urticaria—Irbesartan—type 2 diabetes mellitus	2.35e-05	0.000147	CcSEcCtD
Aripiprazole—Shock—Ramipril—type 2 diabetes mellitus	2.35e-05	0.000147	CcSEcCtD
Aripiprazole—Headache—Gliclazide—type 2 diabetes mellitus	2.35e-05	0.000147	CcSEcCtD
Aripiprazole—Nervous system disorder—Ramipril—type 2 diabetes mellitus	2.34e-05	0.000147	CcSEcCtD
Aripiprazole—Body temperature increased—Irbesartan—type 2 diabetes mellitus	2.34e-05	0.000147	CcSEcCtD
Aripiprazole—Abdominal pain—Irbesartan—type 2 diabetes mellitus	2.34e-05	0.000147	CcSEcCtD
Aripiprazole—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	2.34e-05	0.000146	CcSEcCtD
Aripiprazole—Tachycardia—Ramipril—type 2 diabetes mellitus	2.33e-05	0.000146	CcSEcCtD
Aripiprazole—Diarrhoea—Orlistat—type 2 diabetes mellitus	2.33e-05	0.000146	CcSEcCtD
Aripiprazole—Skin disorder—Ramipril—type 2 diabetes mellitus	2.32e-05	0.000145	CcSEcCtD
Aripiprazole—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	2.31e-05	0.000145	CcSEcCtD
Aripiprazole—Feeling abnormal—Losartan—type 2 diabetes mellitus	2.3e-05	0.000144	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	2.28e-05	0.000143	CcSEcCtD
Aripiprazole—Dizziness—Valsartan—type 2 diabetes mellitus	2.28e-05	0.000143	CcSEcCtD
Aripiprazole—Anorexia—Ramipril—type 2 diabetes mellitus	2.28e-05	0.000143	CcSEcCtD
Aripiprazole—Dizziness—Orlistat—type 2 diabetes mellitus	2.25e-05	0.000141	CcSEcCtD
Aripiprazole—Asthenia—Metformin—type 2 diabetes mellitus	2.25e-05	0.000141	CcSEcCtD
Aripiprazole—Hypotension—Ramipril—type 2 diabetes mellitus	2.23e-05	0.00014	CcSEcCtD
Aripiprazole—Nausea—Gliclazide—type 2 diabetes mellitus	2.23e-05	0.000139	CcSEcCtD
Aripiprazole—Pruritus—Metformin—type 2 diabetes mellitus	2.22e-05	0.000139	CcSEcCtD
Aripiprazole—Urticaria—Losartan—type 2 diabetes mellitus	2.21e-05	0.000139	CcSEcCtD
Aripiprazole—Abdominal pain—Losartan—type 2 diabetes mellitus	2.2e-05	0.000138	CcSEcCtD
Aripiprazole—Body temperature increased—Losartan—type 2 diabetes mellitus	2.2e-05	0.000138	CcSEcCtD
Aripiprazole—Vomiting—Valsartan—type 2 diabetes mellitus	2.19e-05	0.000137	CcSEcCtD
Aripiprazole—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	2.18e-05	0.000137	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	2.18e-05	0.000136	CcSEcCtD
Aripiprazole—Rash—Valsartan—type 2 diabetes mellitus	2.17e-05	0.000136	CcSEcCtD
Aripiprazole—Dermatitis—Valsartan—type 2 diabetes mellitus	2.17e-05	0.000136	CcSEcCtD
Aripiprazole—Vomiting—Orlistat—type 2 diabetes mellitus	2.16e-05	0.000136	CcSEcCtD
Aripiprazole—Insomnia—Ramipril—type 2 diabetes mellitus	2.16e-05	0.000135	CcSEcCtD
Aripiprazole—Headache—Valsartan—type 2 diabetes mellitus	2.16e-05	0.000135	CcSEcCtD
Aripiprazole—Diarrhoea—Metformin—type 2 diabetes mellitus	2.15e-05	0.000134	CcSEcCtD
Aripiprazole—Rash—Orlistat—type 2 diabetes mellitus	2.15e-05	0.000134	CcSEcCtD
Aripiprazole—Paraesthesia—Ramipril—type 2 diabetes mellitus	2.14e-05	0.000134	CcSEcCtD
Aripiprazole—Dermatitis—Orlistat—type 2 diabetes mellitus	2.14e-05	0.000134	CcSEcCtD
Aripiprazole—Headache—Orlistat—type 2 diabetes mellitus	2.13e-05	0.000134	CcSEcCtD
Aripiprazole—Dyspnoea—Ramipril—type 2 diabetes mellitus	2.13e-05	0.000133	CcSEcCtD
Aripiprazole—Asthenia—Irbesartan—type 2 diabetes mellitus	2.12e-05	0.000133	CcSEcCtD
Aripiprazole—Somnolence—Ramipril—type 2 diabetes mellitus	2.12e-05	0.000133	CcSEcCtD
Aripiprazole—Dyspepsia—Ramipril—type 2 diabetes mellitus	2.1e-05	0.000132	CcSEcCtD
Aripiprazole—Pruritus—Irbesartan—type 2 diabetes mellitus	2.09e-05	0.000131	CcSEcCtD
Aripiprazole—Decreased appetite—Ramipril—type 2 diabetes mellitus	2.08e-05	0.00013	CcSEcCtD
Aripiprazole—Dizziness—Metformin—type 2 diabetes mellitus	2.07e-05	0.00013	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	2.06e-05	0.000129	CcSEcCtD
Aripiprazole—Fatigue—Ramipril—type 2 diabetes mellitus	2.06e-05	0.000129	CcSEcCtD
Aripiprazole—Hypersensitivity—Losartan—type 2 diabetes mellitus	2.05e-05	0.000129	CcSEcCtD
Aripiprazole—Nausea—Valsartan—type 2 diabetes mellitus	2.05e-05	0.000128	CcSEcCtD
Aripiprazole—Constipation—Ramipril—type 2 diabetes mellitus	2.04e-05	0.000128	CcSEcCtD
Aripiprazole—Diarrhoea—Irbesartan—type 2 diabetes mellitus	2.02e-05	0.000127	CcSEcCtD
Aripiprazole—Nausea—Orlistat—type 2 diabetes mellitus	2.02e-05	0.000127	CcSEcCtD
Aripiprazole—Asthenia—Losartan—type 2 diabetes mellitus	2e-05	0.000125	CcSEcCtD
Aripiprazole—Vomiting—Metformin—type 2 diabetes mellitus	1.99e-05	0.000125	CcSEcCtD
Aripiprazole—Rash—Metformin—type 2 diabetes mellitus	1.98e-05	0.000124	CcSEcCtD
Aripiprazole—Dermatitis—Metformin—type 2 diabetes mellitus	1.98e-05	0.000124	CcSEcCtD
Aripiprazole—Pruritus—Losartan—type 2 diabetes mellitus	1.97e-05	0.000123	CcSEcCtD
Aripiprazole—Feeling abnormal—Ramipril—type 2 diabetes mellitus	1.97e-05	0.000123	CcSEcCtD
Aripiprazole—Headache—Metformin—type 2 diabetes mellitus	1.96e-05	0.000123	CcSEcCtD
Aripiprazole—Dizziness—Irbesartan—type 2 diabetes mellitus	1.96e-05	0.000123	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	1.95e-05	0.000122	CcSEcCtD
Aripiprazole—Diarrhoea—Losartan—type 2 diabetes mellitus	1.91e-05	0.000119	CcSEcCtD
Aripiprazole—Urticaria—Ramipril—type 2 diabetes mellitus	1.9e-05	0.000119	CcSEcCtD
Aripiprazole—Abdominal pain—Ramipril—type 2 diabetes mellitus	1.89e-05	0.000118	CcSEcCtD
Aripiprazole—Body temperature increased—Ramipril—type 2 diabetes mellitus	1.89e-05	0.000118	CcSEcCtD
Aripiprazole—Vomiting—Irbesartan—type 2 diabetes mellitus	1.88e-05	0.000118	CcSEcCtD
Aripiprazole—Rash—Irbesartan—type 2 diabetes mellitus	1.87e-05	0.000117	CcSEcCtD
Aripiprazole—Dermatitis—Irbesartan—type 2 diabetes mellitus	1.86e-05	0.000117	CcSEcCtD
Aripiprazole—Nausea—Metformin—type 2 diabetes mellitus	1.86e-05	0.000117	CcSEcCtD
Aripiprazole—Headache—Irbesartan—type 2 diabetes mellitus	1.85e-05	0.000116	CcSEcCtD
Aripiprazole—Dizziness—Losartan—type 2 diabetes mellitus	1.84e-05	0.000115	CcSEcCtD
Aripiprazole—Vomiting—Losartan—type 2 diabetes mellitus	1.77e-05	0.000111	CcSEcCtD
Aripiprazole—Hypersensitivity—Ramipril—type 2 diabetes mellitus	1.76e-05	0.00011	CcSEcCtD
Aripiprazole—Nausea—Irbesartan—type 2 diabetes mellitus	1.76e-05	0.00011	CcSEcCtD
Aripiprazole—Rash—Losartan—type 2 diabetes mellitus	1.76e-05	0.00011	CcSEcCtD
Aripiprazole—Dermatitis—Losartan—type 2 diabetes mellitus	1.75e-05	0.00011	CcSEcCtD
Aripiprazole—Headache—Losartan—type 2 diabetes mellitus	1.74e-05	0.000109	CcSEcCtD
Aripiprazole—Asthenia—Ramipril—type 2 diabetes mellitus	1.71e-05	0.000107	CcSEcCtD
Aripiprazole—Pruritus—Ramipril—type 2 diabetes mellitus	1.69e-05	0.000106	CcSEcCtD
Aripiprazole—Nausea—Losartan—type 2 diabetes mellitus	1.65e-05	0.000104	CcSEcCtD
Aripiprazole—Diarrhoea—Ramipril—type 2 diabetes mellitus	1.63e-05	0.000102	CcSEcCtD
Aripiprazole—Dizziness—Ramipril—type 2 diabetes mellitus	1.58e-05	9.89e-05	CcSEcCtD
Aripiprazole—Vomiting—Ramipril—type 2 diabetes mellitus	1.52e-05	9.51e-05	CcSEcCtD
Aripiprazole—Rash—Ramipril—type 2 diabetes mellitus	1.51e-05	9.43e-05	CcSEcCtD
Aripiprazole—Dermatitis—Ramipril—type 2 diabetes mellitus	1.5e-05	9.42e-05	CcSEcCtD
Aripiprazole—Headache—Ramipril—type 2 diabetes mellitus	1.5e-05	9.37e-05	CcSEcCtD
Aripiprazole—Nausea—Ramipril—type 2 diabetes mellitus	1.42e-05	8.88e-05	CcSEcCtD
Aripiprazole—ADRB1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1e-06	9.89e-06	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1e-06	9.87e-06	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—EGFR—type 2 diabetes mellitus	1e-06	9.87e-06	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	9.97e-07	9.83e-06	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.93e-07	9.8e-06	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.92e-07	9.78e-06	CbGpPWpGaD
Aripiprazole—ADRA2C—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	9.91e-07	9.77e-06	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.88e-07	9.74e-06	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—RELA—type 2 diabetes mellitus	9.88e-07	9.74e-06	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.87e-07	9.74e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	9.84e-07	9.7e-06	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.83e-07	9.69e-06	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—CASP3—type 2 diabetes mellitus	9.82e-07	9.68e-06	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	9.8e-07	9.67e-06	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	9.77e-07	9.64e-06	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling by GPCR—IL6—type 2 diabetes mellitus	9.75e-07	9.62e-06	CbGpPWpGaD
Aripiprazole—ADRA1B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	9.75e-07	9.62e-06	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.74e-07	9.61e-06	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.72e-07	9.59e-06	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—RELA—type 2 diabetes mellitus	9.72e-07	9.58e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	9.71e-07	9.58e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	9.71e-07	9.58e-06	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—RELA—type 2 diabetes mellitus	9.7e-07	9.56e-06	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—RELA—type 2 diabetes mellitus	9.67e-07	9.53e-06	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—CASP3—type 2 diabetes mellitus	9.66e-07	9.53e-06	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	9.66e-07	9.53e-06	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.64e-07	9.51e-06	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—RELA—type 2 diabetes mellitus	9.63e-07	9.5e-06	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.63e-07	9.5e-06	CbGpPWpGaD
Aripiprazole—DRD5—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.61e-07	9.48e-06	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling by GPCR—IL6—type 2 diabetes mellitus	9.6e-07	9.47e-06	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.59e-07	9.46e-06	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.55e-07	9.42e-06	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—RELA—type 2 diabetes mellitus	9.54e-07	9.41e-06	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.54e-07	9.41e-06	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—RELA—type 2 diabetes mellitus	9.52e-07	9.38e-06	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.49e-07	9.36e-06	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.46e-07	9.33e-06	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.44e-07	9.31e-06	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	9.41e-07	9.29e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	9.39e-07	9.26e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	9.39e-07	9.26e-06	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.3e-07	9.17e-06	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.28e-07	9.15e-06	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.25e-07	9.12e-06	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—SRC—type 2 diabetes mellitus	9.24e-07	9.11e-06	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.19e-07	9.06e-06	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.18e-07	9.05e-06	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—SRC—type 2 diabetes mellitus	9.16e-07	9.03e-06	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.13e-07	9.01e-06	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.07e-07	8.94e-06	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.03e-07	8.91e-06	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	9.03e-07	8.91e-06	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.01e-07	8.89e-06	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9e-07	8.88e-06	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9e-07	8.87e-06	CbGpPWpGaD
Aripiprazole—DRD2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	8.99e-07	8.87e-06	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.92e-07	8.8e-06	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—CASP3—type 2 diabetes mellitus	8.91e-07	8.79e-06	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.89e-07	8.77e-06	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—INS—type 2 diabetes mellitus	8.86e-07	8.74e-06	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	8.86e-07	8.73e-06	CbGpPWpGaD
Aripiprazole—DRD2—Signaling by GPCR—IL6—type 2 diabetes mellitus	8.85e-07	8.73e-06	CbGpPWpGaD
Aripiprazole—HTR2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	8.85e-07	8.73e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—RELA—type 2 diabetes mellitus	8.84e-07	8.72e-06	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—SRC—type 2 diabetes mellitus	8.84e-07	8.72e-06	CbGpPWpGaD
Aripiprazole—HRH1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	8.83e-07	8.71e-06	CbGpPWpGaD
Aripiprazole—CHRM1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	8.8e-07	8.68e-06	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—SRC—type 2 diabetes mellitus	8.79e-07	8.67e-06	CbGpPWpGaD
Aripiprazole—CHRM3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	8.77e-07	8.65e-06	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	8.76e-07	8.64e-06	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—CASP3—type 2 diabetes mellitus	8.75e-07	8.63e-06	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	8.72e-07	8.6e-06	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	8.71e-07	8.59e-06	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—CASP3—type 2 diabetes mellitus	8.69e-07	8.57e-06	CbGpPWpGaD
Aripiprazole—HRH1—Signaling by GPCR—IL6—type 2 diabetes mellitus	8.69e-07	8.57e-06	CbGpPWpGaD
Aripiprazole—CHRM2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	8.69e-07	8.57e-06	CbGpPWpGaD
Aripiprazole—ADRA1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	8.66e-07	8.54e-06	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	8.66e-07	8.54e-06	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling by GPCR—IL6—type 2 diabetes mellitus	8.63e-07	8.52e-06	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.61e-07	8.49e-06	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—CASP3—type 2 diabetes mellitus	8.61e-07	8.49e-06	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	8.58e-07	8.46e-06	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.57e-07	8.45e-06	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—SRC—type 2 diabetes mellitus	8.55e-07	8.44e-06	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling by GPCR—IL6—type 2 diabetes mellitus	8.55e-07	8.43e-06	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	8.53e-07	8.41e-06	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	8.51e-07	8.39e-06	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—SRC—type 2 diabetes mellitus	8.42e-07	8.3e-06	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—MMP9—type 2 diabetes mellitus	8.42e-07	8.3e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	8.37e-07	8.26e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	8.37e-07	8.26e-06	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	8.35e-07	8.23e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	8.33e-07	8.22e-06	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.33e-07	8.22e-06	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	8.33e-07	8.21e-06	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	8.28e-07	8.17e-06	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—MMP9—type 2 diabetes mellitus	8.27e-07	8.15e-06	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.26e-07	8.15e-06	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	8.24e-07	8.13e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	8.22e-07	8.11e-06	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—MMP9—type 2 diabetes mellitus	8.21e-07	8.1e-06	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.2e-07	8.09e-06	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	8.2e-07	8.08e-06	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.19e-07	8.07e-06	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	8.18e-07	8.07e-06	CbGpPWpGaD
Aripiprazole—DRD2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	8.16e-07	8.05e-06	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	8.15e-07	8.04e-06	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—MMP9—type 2 diabetes mellitus	8.13e-07	8.02e-06	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	8.13e-07	8.01e-06	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	8.12e-07	8.01e-06	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	8.11e-07	8e-06	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.1e-07	7.99e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	8.05e-07	7.94e-06	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	8.05e-07	7.94e-06	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—IL6—type 2 diabetes mellitus	8.04e-07	7.93e-06	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—IL6—type 2 diabetes mellitus	8.04e-07	7.93e-06	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	8.03e-07	7.92e-06	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.03e-07	7.92e-06	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	8.02e-07	7.91e-06	CbGpPWpGaD
Aripiprazole—HRH1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	8.02e-07	7.91e-06	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	7.99e-07	7.88e-06	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—IL6—type 2 diabetes mellitus	7.98e-07	7.87e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	7.98e-07	7.87e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	7.97e-07	7.87e-06	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	7.97e-07	7.86e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	7.92e-07	7.81e-06	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.9e-07	7.79e-06	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	7.89e-07	7.78e-06	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	7.87e-07	7.76e-06	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.86e-07	7.75e-06	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—IL6—type 2 diabetes mellitus	7.82e-07	7.71e-06	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	7.77e-07	7.66e-06	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	7.77e-07	7.66e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	7.76e-07	7.66e-06	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—SRC—type 2 diabetes mellitus	7.76e-07	7.65e-06	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.75e-07	7.64e-06	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.71e-07	7.6e-06	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—IL6—type 2 diabetes mellitus	7.69e-07	7.59e-06	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	7.65e-07	7.55e-06	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.65e-07	7.54e-06	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—SRC—type 2 diabetes mellitus	7.64e-07	7.53e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	7.62e-07	7.52e-06	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—SRC—type 2 diabetes mellitus	7.62e-07	7.52e-06	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—SRC—type 2 diabetes mellitus	7.6e-07	7.49e-06	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—IL6—type 2 diabetes mellitus	7.59e-07	7.48e-06	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—SRC—type 2 diabetes mellitus	7.57e-07	7.47e-06	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.56e-07	7.46e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	7.54e-07	7.43e-06	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.53e-07	7.42e-06	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—SRC—type 2 diabetes mellitus	7.5e-07	7.4e-06	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.5e-07	7.39e-06	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—SRC—type 2 diabetes mellitus	7.48e-07	7.38e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	7.46e-07	7.36e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.46e-07	7.35e-06	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.44e-07	7.34e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	7.43e-07	7.33e-06	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.42e-07	7.32e-06	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.42e-07	7.32e-06	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.41e-07	7.31e-06	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.4e-07	7.3e-06	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.38e-07	7.28e-06	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.37e-07	7.27e-06	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.36e-07	7.26e-06	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—IL6—type 2 diabetes mellitus	7.34e-07	7.24e-06	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	7.32e-07	7.22e-06	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	7.32e-07	7.22e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	7.31e-07	7.21e-06	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.3e-07	7.2e-06	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.28e-07	7.18e-06	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—IL6—type 2 diabetes mellitus	7.27e-07	7.17e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	7.24e-07	7.14e-06	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.21e-07	7.11e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	7.15e-07	7.05e-06	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	7.1e-07	7.01e-06	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.1e-07	7e-06	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—AKT1—type 2 diabetes mellitus	7e-07	6.9e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—SRC—type 2 diabetes mellitus	6.95e-07	6.85e-06	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.94e-07	6.84e-06	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—IL6—type 2 diabetes mellitus	6.92e-07	6.83e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	6.86e-07	6.77e-06	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—IL6—type 2 diabetes mellitus	6.83e-07	6.74e-06	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.83e-07	6.73e-06	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.81e-07	6.72e-06	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.8e-07	6.71e-06	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.79e-07	6.7e-06	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.77e-07	6.68e-06	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.77e-07	6.68e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.77e-07	6.67e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	6.73e-07	6.64e-06	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.7e-07	6.61e-06	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.7e-07	6.61e-06	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	6.69e-07	6.6e-06	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.69e-07	6.6e-06	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.68e-07	6.59e-06	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.68e-07	6.59e-06	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.66e-07	6.57e-06	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.64e-07	6.55e-06	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.57e-07	6.48e-06	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.55e-07	6.46e-06	CbGpPWpGaD
Aripiprazole—CYP3A7—Metabolism—AKT1—type 2 diabetes mellitus	6.55e-07	6.46e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	6.52e-07	6.43e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	6.41e-07	6.32e-06	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.39e-07	6.3e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	6.39e-07	6.3e-06	CbGpPWpGaD
Aripiprazole—ADRA2C—Metabolism—AKT1—type 2 diabetes mellitus	6.36e-07	6.27e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	6.31e-07	6.23e-06	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.3e-07	6.22e-06	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—IL6—type 2 diabetes mellitus	6.23e-07	6.14e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.21e-07	6.13e-06	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—IL6—type 2 diabetes mellitus	6.17e-07	6.08e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.09e-07	6.01e-06	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—IL6—type 2 diabetes mellitus	5.95e-07	5.87e-06	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—IL6—type 2 diabetes mellitus	5.92e-07	5.84e-06	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—IL6—type 2 diabetes mellitus	5.76e-07	5.68e-06	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.74e-07	5.66e-06	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.69e-07	5.61e-06	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—IL6—type 2 diabetes mellitus	5.67e-07	5.59e-06	CbGpPWpGaD
Aripiprazole—CHRM3—Metabolism—AKT1—type 2 diabetes mellitus	5.63e-07	5.55e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	5.56e-07	5.49e-06	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.49e-07	5.42e-06	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.46e-07	5.39e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	5.46e-07	5.38e-06	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.32e-07	5.24e-06	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.23e-07	5.16e-06	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—IL6—type 2 diabetes mellitus	5.23e-07	5.16e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—AKT1—type 2 diabetes mellitus	5.16e-07	5.09e-06	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—IL6—type 2 diabetes mellitus	5.14e-07	5.07e-06	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—IL6—type 2 diabetes mellitus	5.13e-07	5.06e-06	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—IL6—type 2 diabetes mellitus	5.12e-07	5.05e-06	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—IL6—type 2 diabetes mellitus	5.1e-07	5.03e-06	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—IL6—type 2 diabetes mellitus	5.05e-07	4.98e-06	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—IL6—type 2 diabetes mellitus	5.04e-07	4.97e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	5e-07	4.93e-06	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.82e-07	4.76e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	4.79e-07	4.72e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	4.79e-07	4.72e-06	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.75e-07	4.68e-06	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.74e-07	4.67e-06	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	4.73e-07	4.67e-06	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.72e-07	4.66e-06	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.71e-07	4.64e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—IL6—type 2 diabetes mellitus	4.68e-07	4.62e-06	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.66e-07	4.6e-06	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.65e-07	4.58e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	4.38e-07	4.32e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.32e-07	4.26e-06	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	3.57e-07	3.52e-06	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	3.36e-07	3.32e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	2.2e-07	2.17e-06	CbGpPWpGaD
